U.S., July 29 -- ClinicalTrials.gov registry received information related to the study (NCT07730489) titled 'A Study Comparing BL-M07D1 With Physician's Choice Therapy in Patients With HER2 IHC3+ Advanced Colorectal Cancer Who Failed Prior Treatment With Oxaliplatin, Fluorouracil and Irinotecan' on July 23.
Brief Summary: This trial is a registrational Phase III, randomized, open-label, multicenter study designed to evaluate the efficacy and safety of BL-M07D1 in patients with advanced colorectal cancer who have HER2 IHC3+ and have failed prior treatment with oxaliplatin, fluorouracil and irinotecan.
Study Start Date: Aug., 2026
Study Type: INTERVENTIONAL
Condition:
Colorectal Cancer
Intervention:
DRUG: BL-M07D1
Administration by in...